LRRK2 and Crohn disease: In a second and independent study, we cultured PBMC from patients with Crohn’s disease with Needle-Tox alone in the absence and presence of the LRRK2-kinase inhibitors, LRRK2-IN-1 and CZC54252.HCl, as indicated in Methods.